Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Signe Regner Michaelsen |
| Publication date | January 5, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |